ENDRA Life Sciences Inc. announced on March 25, 2026, that it reduced its employee count to minimize costs, expecting to incur about $51,000 in severance charges as part of a strategic review process aimed at maximizing shareholder value. This change reflects a shift in the company's strategy while continuing operations in their TAEUS business.